Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023. Horizon Therapeutics was founded in 2005 in Illinois focused on the development of Duexa, a formulation of ibuprofen combined with famotidine. Nitec Pharma AG was founded in Switzerland in 2004 as a spin-off from Merck KGaA. In 2010, Horizon and Nitec merged to form a combined company Horizon Pharma Inc. to be led by Timothy Walbert to support the launch of Lodotra and Duexa. Horizon IPOed in 2011 raising $49.5 million. More information...
According to PR-model, horizonpharma.com is ranked 3,890,715th in multilingual Wikipedia, in particular this website is ranked 2,072,692nd in English Wikipedia.
The website is placed before leopharma.de and after guerbet.de in the BestRef global ranking of the most important sources of Wikipedia.
